Home / Aprepitant / United States
US ATC A04AD12 · updated 2 Nov 2026
Aprepitant shortage in United States
Is there an Aprepitant shortage in United States?
Yes. As of 2 Nov 2026, 1 Aprepitant product is reported short in United States, the first since 8 Apr 2026. No return date has been given. Main reason: not stated.
Also short in Canada, Germany, France, Italy, Spain, Ireland, Austria, Czechia, Norway, Sweden, Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Emend, Oral Powder for Suspension, 125 mg (NDC 0006-3066-03) discontinuation | Merck Sharp & Dohme LLC | 8 Apr 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).